Operator Good day, and welcome to the CorMedix Inc. fourth-quarter and full-year 2024 financial results conference call. All ...

Survey respondents preferred patient portal messages written by AI, but their satisfaction decreased when they were told that messages were written by AI.

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

Walter notes that despite the progress Kenya has made in the fight against TB, President Donald Trump’s stop order on foreign ...

SLE is a multisystem autoimmune disease where periods of disease activity, often difficult to predict, can cause irreversible disease damage. This study aimed to develop a patient-centric predictive ...

If successful, local officials could expand the program to other artistic activities like theater or dance, Courcier ...

Patients may not feel comfortable making that financial promise, often before they have any idea what the charges will be.

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

AHA comments regarding the Drug Enforcement Administration’s proposed rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations.

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

The Minnesota Attorney General's Office investigation into Mayo Clinic found that it deterred some patients from applying for ...

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...